IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MAURI, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.711
AS - Asia 2.213
NA - Nord America 1.679
SA - Sud America 195
AF - Africa 62
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.897
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 1.845
US - Stati Uniti d'America 1.612
CN - Cina 981
GB - Regno Unito 655
SG - Singapore 533
IT - Italia 491
HK - Hong Kong 180
BR - Brasile 144
IN - India 121
SE - Svezia 113
RU - Federazione Russa 101
NL - Olanda 95
FR - Francia 72
JP - Giappone 69
ID - Indonesia 59
ES - Italia 58
IE - Irlanda 56
VN - Vietnam 55
FI - Finlandia 53
CA - Canada 46
TR - Turchia 45
KR - Corea 42
TW - Taiwan 33
AU - Australia 32
DK - Danimarca 26
AT - Austria 25
CI - Costa d'Avorio 20
AR - Argentina 19
NO - Norvegia 17
BE - Belgio 16
PL - Polonia 16
GR - Grecia 15
PH - Filippine 15
MX - Messico 11
RO - Romania 11
UA - Ucraina 11
CO - Colombia 10
ZA - Sudafrica 9
IR - Iran 8
JO - Giordania 8
TH - Thailandia 8
CH - Svizzera 7
IL - Israele 7
EC - Ecuador 6
EG - Egitto 6
PK - Pakistan 6
PT - Portogallo 6
HU - Ungheria 5
LU - Lussemburgo 5
MA - Marocco 5
QA - Qatar 5
SC - Seychelles 5
SD - Sudan 5
UZ - Uzbekistan 5
VE - Venezuela 5
BD - Bangladesh 4
BO - Bolivia 4
EE - Estonia 4
IQ - Iraq 4
MY - Malesia 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
AM - Armenia 3
CZ - Repubblica Ceca 3
KE - Kenya 3
LT - Lituania 3
CL - Cile 2
CR - Costa Rica 2
CU - Cuba 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
OM - Oman 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SN - Senegal 1
TJ - Tagikistan 1
YE - Yemen 1
Totale 7.897
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.706
Southend 563
Singapore 273
Ashburn 270
Milan 175
Hong Kong 143
Beijing 130
Dallas 124
Hefei 120
Chandler 110
Los Angeles 67
Shanghai 65
Dublin 56
Guangzhou 50
Fairfield 49
Jakarta 49
Santa Clara 49
Bengaluru 45
Houston 43
Council Bluffs 42
Turin 41
Nanjing 39
Phoenix 39
Dearborn 36
Princeton 36
Istanbul 34
Munich 33
New York 32
Wilmington 32
Tokyo 30
Hangzhou 24
Buffalo 23
Chicago 23
Helsinki 23
Hyderabad 22
Cambridge 21
Abidjan 20
Changsha 20
Jinan 20
Rome 20
Ann Arbor 19
Moscow 19
Ottawa 19
Redwood City 19
Woodbridge 19
Barcelona 18
London 18
Lappeenranta 17
Madrid 16
Ho Chi Minh City 15
Boston 14
Cangzhou 14
Chengdu 14
Fuzhou 14
Heidelberg 14
Seattle 14
Shenyang 14
Vienna 14
Berlin 13
Hanoi 13
Nuremberg 13
Seoul 13
Oslo 12
Turku 12
Brussels 11
Atlanta 10
Boardman 10
Des Moines 10
Fremont 10
Melbourne 10
São Paulo 10
Taipei 10
Amsterdam 9
Shenzhen 9
Toronto 9
Central 8
Columbus 8
Florence 8
Manchester 8
Redmond 8
Salt Lake City 8
Tianjin 8
Xiamen 8
Central District 7
Chennai 7
Miami 7
Monza 7
Paris 7
Roubaix 7
Silver Spring 7
Upper Marlboro 7
Wuhan 7
Athens 6
Bari 6
Brisbane 6
Buenos Aires 6
Carrara 6
Hebei 6
Messina 6
Nanyang 6
Totale 5.347
Salva come PNG Salva come JPEG
Nome #
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin 729
Early-onset colorectal cancer in young individuals 631
Increased incidence of colon cancer among individuals younger than 50 years : a 17 years analysis from the cancer registry of the municipality of Milan, Italy 437
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 307
The DNA Damage Response pathway as a land of therapeutic opportunities for colorectal cancer 279
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 254
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer 237
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 222
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 219
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 214
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA 212
Strategies to tackle RAS-mutated metastatic colorectal cancer 207
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature 192
Circulating tumor DNA to drive treatment in metastatic colorectal cancer 186
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review 183
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer 175
Oxaliplatin retreatment in metastatic colorectal cancer : systematic review and future research opportunities 171
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study 169
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies 168
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study 167
The evolutionary landscape of treatment for BRAFv600e mutant metastatic colorectal cancer 166
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer 162
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids 161
Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea 159
TRKA expression and NTRK1 gene copy number across solid tumours 159
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer 158
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report 158
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers 157
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers 154
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer 153
Application of histology-agnostic treatments in metastatic colorectal cancer 145
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial 142
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 133
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells 119
Early-onset cancers: Biological bases and clinical implications 117
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review 115
Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer 105
FROM CHEMO-RESISTANCE PREDICTION TO THE IDENTIFICATION OF NEW POTENTIAL THERAPEUTIC STRATEGIES FOR CHEMO-RESISTANT MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER: THE OCEANUS STUDY 93
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition 81
Tumor "age" in early-onset colorectal cancer 67
Totale 8.063
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.516
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 56 40 39 50 63 26 43
2021/2022546 66 51 60 69 36 14 31 39 73 24 37 46
2022/2023735 54 52 47 45 61 131 43 50 91 21 83 57
2023/20241.914 63 64 92 67 156 87 245 227 129 215 287 282
2024/20252.159 243 256 243 221 110 95 113 157 104 157 150 310
2025/20261.579 359 304 405 254 237 20 0 0 0 0 0 0
Totale 8.063